Sage Journals: Discover world-class research

Retricted access

Review article

First published 2010-3

IL-12/23 Inhibitors and Their Potential Benefits and Risks for Psoriasis Patients

Megan A. Kinney, Brad A. Yentzer, Steven R. Feldman

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Letter

First published 2025

Characteristics,Management,and Outcomes of Latent Tuberculosis Reactivation Following the Use of Biologics for Psoriasis: A Systematic Review

Darshana Seeburruth, Jazlyn McGuinty, Siddhartha Sood [...]

Journal of Cutaneous Medicine and Surgery

Retricted access

Review article

First published 2014-12

Reviewing the Guidelines for Tuberculosis Screening in Psoriasis Patients Treated with Biologics

Young M. Choi, Jashin J. Wu

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Review article

First published 2022-4

TNF-Alpha Inhibitors and Ustekinumab for the Treatment of Psoriasis: Therapeutic Utility in the Era of IL-17 and IL-23 Inhibitors

Julie J. Hong, Edward K. Hadeler, Megan L. Mosca [...]

Journal of Psoriasis and Psoriatic Arthritis®

Open access

Review article

First published 2024

Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies

Cristina Bezzio, Carolina Aliai Micol Cavalli, Gianluca Franchellucci [...]

Therapeutic Advances in Gastroenterology

Retricted access

Review article

First published 2025

Clinical Considerations for the Use of Biologic Agents in Psoriasis Patients With a History of Lymphoma

Allison Bai, Emily Gartrell, Olivia Whittaker [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Research article

First published 2023-1

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Wei Jing Loo, Irina Turchin, Vimal H. Prajapati [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2019

IL-12/IL-23p40 identified as a downstream target of apremilast in ex vivo models of arthritis

Tue W. Kragstrup, Mary Adams, Søren Lomholt [...]

Therapeutic Advances in Musculoskeletal Disease

Free access

Research article

First published 2013-10

Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential

Alice Gottlieb, Kirti Narang

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2025

Biomarkers for successful tapering of a tumor necrosis factor inhibitor in patients with radiographic axial spondyloarthritis: A pilot study

Hong Ki Min, Ji-Yeon Lee

Sage Open Medicine

Search results